Earnings Labs

The Toronto-Dominion Bank (TD)

Q4 2007 Earnings Call· Mon, Mar 17, 2008

$104.52

-0.82%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+5.51%

1 Week

+4.84%

1 Month

+4.61%

vs S&P

-2.21%

Transcript

Operator

Operator

Good morning, ladies and gentlemen, and thank you for joining the Cowen Group Incorporated conference call to discuss the financial results for the fourth quarter and 12 months ended December 31, 2007. By now, you should have received a copy of the company's earnings release, which can be accessed at the Cowen Group Incorporated's website, at www.cowen.com. If you do have Internet access and would like the copy of the press release, please call Nicole Keeler at area code 646-562-1796. Before we begin, the company has asked me to remind you that some of the comments made on today's call and some of the responses to your question may contain forward-looking statements. These statements are subject to the risks and uncertainties described in the company's earnings release and other filings with the SEC. Cowen Group Incorporated has no obligation to update the information presented on the call. A more complete description of these and other risks, uncertainties and assumptions is included in the company's filings with SEC, which are available on the company's website and on the SEC website, at www.sec.gov. Also on today's call our speakers will reference certain non-GAAP financial measures which the company believes will provide useful information for investors. Reconciliation of those measures to GAAP is consistent with the company's reconciliation as presented in today's earnings release. Now, I would like to turn the call over to Mr. Kim Fennebresque, Chairman and Chief Executive Officer, who is joined today by Mr. Tom Conner, Chief Financial Officer. Gentlemen, you may begin.

Kim Fennebresque

Chairman

Good morning and thank you for joining our call. I'm going to start this morning with our results for the fourth quarter and full year before spending some time discussing the market turmoil on the fourth quarter and its impact on our business. I will then turn the call over to Tom, who will review the financial information for the quarter in greater detail. For the fourth quarter of 2007, revenue decreased from the fourth quarter of 2006 by $38.1 million to $59.3 million on weaker investment banking results, primarily due to decreased capital raising activity. Our adjusted net operating loss for the fourth quarter of 2007 was $9.2 million compared to adjusted net operating income of $8.3 million in the fourth quarter of 2006. We recorded a GAAP net loss of $10.7 million for the quarter compared to GAAP net income of $7.2 million in the fourth quarter of 2006. Please note that our 2007 fourth quarter results included a $10.1 million cumulative adjustment to compensation expense to bring our compensation ratio to 65% for the full year. For the full year, revenue decrease from 2006 by $83.4 million to $261.6 million. Our adjusted net operating loss for 2007 was $7.4 million, within the range of the $6 million to $8.3 million we provided in our December 10 press release. For 2007, we recorded a GAAP net loss of $11.3 million compared to GAAP net income of $37.9 million in the prior year period. Please note that our 2006 full year results included a $25.8 million one-time gain related to sale of seats on certain exchanges. I'd like to now spend a moment focusing on the market conditions during the fourth quarter and the resulting impact on our business before commenting on the beginning of 2008. I'll then turn…

Tom Conner

Chief Financial Officer

Thank you, Kim. For the quarter December 31, 2007, total revenue was $59.3 million, representing a decrease of 39% from $97.4 million during the same quarter of 2006. Revenues for the full year decreased 24% to $261.6 million as compared to $345 million in 2006. Investment banking revenue for the fourth quarter was $20.6 million, a decrease of $32.5 million compared to the same period in 2006. The decrease primarily reflects lower transaction volumes in our public and private capital raising activities partially offset by an increase in our strategic advisory fees. Before I discuss sales and trading-related revenues, I would like to mention a role-up change. We have combined commissions and principal transactions as well as fees paid to us towards our equity research, which was previously recorded in other revenue into a new revenue line called brokerage. We believe these revenues should all be reviewed on a combined basis as the majority of these revenues are derived from the same group of clients. Brokerage revenue for the fourth quarter of 2007 was $35.1 million, a decrease of $4.9 million compared to $40 million in the same quarter of 2006. The decrease resulted primarily from a reduction in the value of warrant positions that were previously received in connection with investment banking transactions and a decrease in revenues related to our convertible trading activities compared to the fourth quarter of 2006. In addition, the fourth quarter of 2006 included $1.5 million of gains on restricted stock related to our exchange fees. Excluding these items, our core brokerage business increased $0.2 million to $36.1 million for the fourth quarter of 2007, compared to the fourth quarter of 2006. Revenue from interest and dividend income for the fourth quarter of 2007 was $2.3 million compared to $3.2 million in the same…

Operator

Operator

(Operator Instructions) Sir, your first question comes to you from the line of Jeff Harte of Sandler O'Neill. Please proceed.

Jeff Harte - Sandler O'Neill

Analyst · Sandler O'Neill. Please proceed

Good morning, guys. On the brokerage, kind of commission side, the core being of 1% year-over-year, can you talk a little bit about maybe differences between client activities, volumes and loss rates, I mean did one or the other increased by more than 1%? Specifically, I guess I'm looking at trading volumes, seems to be a little stronger. I thought maybe brokerage revenues will be a little higher?

Kim Fennebresque

Chairman

I think our loss ratio has remained fairly constant. So I think after that it's a calculation as to kind of revenue mix among the customer mix.

Jeff Harte - Sandler O'Neill

Analyst · Sandler O'Neill. Please proceed

Okay. Agreeing with your comments that who knows when the markets are going to come back and how important that's going to be for investment banking revenues, how do you look at comp expense through 2008, given that the year is kind of off to a slow start in the equity underwriting? If we don't actually see a decent pickup in industry activity levels in equity origination, we potentially will be looking at another 65% compensation expense ratio here in 2008?

Kim Fennebresque

Chairman

I certainly wouldn't deny the possibility of it, Jeff, having, even to my own surprise, decided to make this decision last fall, although obviously we were the first do that. Several others followed suit quickly there after. We are certainly not going to accrue 65%, and we do expect there will be improvement in activity. As to when and how much, I don't know. So I think my ability of forecast that may be no better than my ability to forecast market activity. So I obviously am probably the last person who should commit a comp to revenue ratio, but suffice it to say that when we went to 65%, we did it with great reluctance.

Jeff Harte - Sandler O'Neill

Analyst · Sandler O'Neill. Please proceed

Okay. And finally, in the pipes business, a lot of kind of the biotech-type companies we look at just being customers of yours, we kind of make the assumption that they only have a limited amount of cash on hand and they're not generally generating revenues, yet eventually they're going to come back to the market. Do you have any kind of a concept, I know this is a 30,000 foot question of how long kind of some of the smaller biotech-type companies can actually hold up before coming back to the market, and actually maybe we see some even at the tough markets some countercyclical capital raises for you there?

Kim Fennebresque

Chairman

That is beyond my specific knowledge. What I will say, one of the things about the pipe business is that it makes it hard to forecast as pipe transactions tend to come and go very quickly. So there really is never much of a pipe backlog. But I think the conclusion you reached that a lot of the early stage life sciences companies that are mostly spending money rather than generate money do need capital in order to stay in business. Certainly, your thesis makes sense. Whether that results in increased private equity activity or not and whether it results in private activity or not with us is obviously an open question.

Jeff Harte - Sandler O'Neill

Analyst · Sandler O'Neill. Please proceed

Okay. Thank you.

Kim Fennebresque

Chairman

You are welcome.

Operator

Operator

Thank you, sir. (Operator Instructions) Gentlemen, there appears to be no further questions at this time. I am going to turn it back to you for your closing remarks. Thank you.

Kim Fennebresque

Chairman

Thank you. Well, I certainly recognize that this has been a difficult period not just for Wall Street generally, but for us in that context. And I assure you that we do all we can everyday to make this all be successful and we will continue to do that on your behalf. Thank you very much. I appreciate your time.

Operator

Operator

Ladies and gentlemen, that concludes your conference for today. You may now disconnect. Have a great day.